HLMRX
Price
$16.17
Change
+$0.46 (+2.93%)
Updated
Apr 9 closing price
Net Assets
333.33M
OSMCX
Price
$30.67
Change
+$1.54 (+5.29%)
Updated
Apr 9 closing price
Net Assets
3.09B
Ad is loading...

HLMRX vs OSMCX

Header iconHLMRX vs OSMCX Comparison
Open Charts HLMRX vs OSMCXBanner chart's image
Harding Loevner Intl Small Coms Instl
Price$16.17
Change+$0.46 (+2.93%)
VolumeN/A
Net Assets333.33M
Invesco International Small-Mid Com C
Price$30.67
Change+$1.54 (+5.29%)
VolumeN/A
Net Assets3.09B
HLMRX vs OSMCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HLMRX vs. OSMCX commentary
Apr 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLMRX is a Hold and OSMCX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
OSMCX has more cash in the bank: 3.09B vs. HLMRX (333M). HLMRX pays higher dividends than OSMCX: HLMRX (1.30) vs OSMCX (0.53). HLMRX was incepted earlier than OSMCX: HLMRX (14 years) vs OSMCX (27 years). OSMCX (2.13) is less costly to investors than HLMRX (1.16). OSMCX is a more actively managed with annual turnover of: 21.00 vs. HLMRX (17.00). OSMCX has a lower initial minimum investment than HLMRX: OSMCX (1000) vs HLMRX (100000). HLMRX annual gain was more profitable for investors over the last year : -11.92 vs. OSMCX (-19.89). HLMRX return over 5 years is better than : 22.30 vs. OSMCX (-17.77).
HLMRXOSMCXHLMRX / OSMCX
Total Expense Ratio1.152.1354%
Annual Report Gross Expense Ratio1.162.1354%
Fund Existence14 years27 years-
Gain YTD-6.434-5.802111%
Front LoadN/AN/A-
Min. Initial Investment100000100010,000%
Min. Initial Investment IRAN/AN/A-
Net Assets333M3.09B11%
Annual Yield % from dividends1.300.53245%
Returns for 1 year-11.92-19.8960%
Returns for 3 years-14.81-27.3254%
Returns for 5 years22.30-17.77-126%
Returns for 10 years17.49-11.96-146%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGICX62.40N/A
N/A
JPMorgan US Value C
RTOUX33.90N/A
N/A
Russell Inv Tax-Managed US Mid&Sm Cap M
FAPMX11.68N/A
N/A
Fidelity Advisor Healthy Future I
HIEMX6.83N/A
N/A
Virtus SGA Emerging Markets Equity I
PMGJX6.09N/A
N/A
Principal MidCap Growth J